First, although high mRNA expressions of S100A2/4/6/10/14/16 were independent prognostic factors for shorter OS of pancreatic cancer patients, the online databases used in this study lacked proteome-level data. This evidence concerns the gene S100A2 and familial pancreatic carcinoma.